金华春光橡塑科技股份有限公司 2025 年第五次临时股东会的 法律意见书 国浩律师（杭州）事务所 关 于 国浩律师（杭州）事务所 关于金华春光橡塑科技股份有限公司 地址：杭州市上城区老复兴路白塔公园 B 区 2 号、15 号国浩律师楼 邮编：310008 Grandall Building, No.2＆No.15, Block B, Baita Park, Old Fuxing Road, Hangzhou, Zhejiang 310008, China 电话/Tel: (+86)(571) 8577 5888 传真/Fax: (+86)(571) 8577 5643 电子邮箱/Mail：grandallhz@grandall.com.cn 网址/Website：http://www.grandall.com.cn 二〇二五年十二月 春光科技 2025 年第五次临时股东会法律意见书 国浩律师（杭州）事务所 2025 年第五次临时股东会的 法律意见书 致：金华春光橡塑科技股份有限公司 国浩律师（杭州）事务所（以下简称"本所"）接受金华春光橡塑科技股份有限公 司（以下简称"公司"）委托指派律师出席公司 2025 ...

| 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 002420 | 毅昌科技 | 7.86 | -6.76% | 60.11万 | 4.72亿 | | 603657 | 春光科技 | 30.87 | -3.38% | 4.83万 | 1.50亿 | | 66900ZG | 海达尔 | 48.20 | -2.45% | 4726.23 | 2294.54万 | | 301252 | 同星科技 | 30.35 | -2.03% | 7.53万 | 2.29亿 | | 002418 | 康盛股份 | 4.94 | -1.98% | 103.73万 | 5.16 Z | | 603578 | 三星新材 | 12.00 | -1.88% | 2.28万 | 2756.15万 | | 600619 | 海立股份 | 21.00 | -1.78% | 28.86万 | 6.09亿 | | 603075 | 热威股份 | 21.67 | -1.54% | 9624.0 | 2099.77万 | | 301135 ...

据央视新闻报道，郭人杰带领的团队正在研发一种服务于家庭的小型具身机器人。 据12月24日公告，春光科技近日获得了乐享科技 OEM/ODM（（OEM与ODM俗称定牌生产和贴牌生产））"W1"和"M1"机器人产品采购订单，金额为 4326.28万元。订单对应供应商为苏州尚腾科技制造有限公司——这是春光科技全资子公司，交货时间在2026年4月30日前。 采购合同披露，春光科技与乐享科技以产品累计订单量为依据，执行阶梯式订单价格。其中，对"M1"产品，如乐享科技的订单累计数量未满30000台而停止 订购，应向春光科技支付产线使用费用150万元；对"W1"产品，如乐享科技订单累计数量未满5000台而停止订购，应向春光科技支付产线使用费用150万 元。 另外，乐享科技向春光科技提供真实可行的装配工艺文件，并协助其建设前述专用产线，必要时向专用产线所在地派驻工程师协助其工作。春光科技按照双 方商定的项目计划，进行产线的建设，工装设备仪器等物品的采买和制作，如双方任一方未能按照约定达成里程碑事件，违约方应承担守约方的损失。 春光科技对此表示，公司本次获得客户的机器人产品采购订单，标志着公司的制造工艺与技术获得了客户的认可，为 ...

Group 1: Overseas News - US stock market has seen five consecutive days of gains, with the Dow Jones up 0.6%, Nasdaq up 0.22%, and S&P 500 up 0.32%. Major tech companies like Apple, Meta, Microsoft, and Amazon saw increases of up to 0.53%, while Tesla, Google A, and Nvidia experienced declines of up to 0.32% [1] - Nvidia denied reports of a $200 million acquisition of AI chip startup Groq, stating that only a licensing agreement for inference technology was reached [1] - Samsung and SK Hynix are reportedly raising HBM3E prices by nearly 20% for next year [1] - Sanofi plans to acquire US vaccine company Dynavax for $2.2 billion to enhance its adult vaccine portfolio [1] Group 2: Domestic Major Events - The People's Bank of China and eight other departments issued opinions to support the construction of the Western Land-Sea New Corridor, exploring cross-border payment trials for digital RMB with Singapore [2][5] Group 3: Market Strategy Insights - Everbright Securities noted that the Shanghai Composite Index has shown strong performance with six consecutive days of gains, indicating a recovery in market sentiment and potential continued inflow of funds, particularly favoring technology growth stocks [3] Group 4: Real Estate Policy Changes - Beijing's new real estate policy, effective December 24, 2025, includes four main aspects: relaxing social security requirements for non-Beijing residents, supporting multi-child families in housing needs, optimizing commercial loan interest rates, and lowering the down payment ratio for second homes [4][5] Group 5: Digital Currency Developments - The digital RMB aims to address inefficiencies and high costs in traditional cross-border payments, with optimistic projections for transaction volumes reaching 162.4 trillion yuan by 2030 [6]

Group 1 - Spring Technology has received a procurement order for robot products from Lexiang Technology amounting to 43.2628 million yuan, marking recognition of its manufacturing technology and laying the foundation for future business expansion in robot products [1] - Huayin Technology signed a framework procurement contract worth 254 million yuan for special functional materials for aircraft fuselage, reflecting the implementation of its strategic layout and enhancing its market position in key materials for aviation engines [2] - Wankai New Materials' subsidiary signed a procurement contract with Lingxin Qiaoshou to provide lightweight components for humanoid robot arms, with a total contract value of 10 million yuan [2] Group 2 - Heng Rui Medicine's injectable SHR-A1904 has been included in the list of breakthrough therapeutic varieties by the National Medical Products Administration, with no similar products approved globally, targeting specific cancer types [3] - Hongda Electronics announced that its indirect holding in Jiangsu Zhanxin's IPO application has been accepted, but the subsequent progress remains uncertain [4] - Jia Heng Jia Hua's controlling shareholder is planning a change in control, leading to a temporary suspension of its stock trading [5]

Suspension and Resumption - Jiaheng Jiahua's controlling shareholder is planning a change in the company's control, leading to a suspension of its stock [1] Buybacks and Increases - Guangqi Technology's controlling shareholder proposed a share buyback of between 50 million to 100 million yuan [2] - Sentai Co., Ltd.'s controlling shareholder intends to increase its stake in the company by no less than 100 million yuan [3] Mergers and Acquisitions - Gaozheng Minexplosion is acquiring 100% equity of Heilongjiang Overseas Explosive Materials Co., Ltd. for a total of 510 million yuan, which includes transferring 31,000 tons of industrial explosive production capacity to Tibet to address production capacity constraints [4] External Investments and Daily Operations - Huaqin Technology signed a contract worth 254 million yuan for special functional materials for aircraft fuselage [5] - Wankai New Materials' subsidiary signed a business contract with Lingxin Qiaoshou to provide lightweight components for humanoid robot arms [5] - Chunguang Technology received a procurement order for robot products worth 43.26 million yuan from Lexiang Technology [6] - Chalco International signed a total EPC contract for a 2.909 billion yuan project to upgrade electrolytic cells in Qingtongxia [7] - Longpan Technology plans to increase the production capacity of its "new energy vehicle power and energy storage battery cathode material" project from 62,500 tons/year to 100,000 tons/year [7] - Heng Rui Pharmaceutical's injectable SHR-A1904 has been included in the list of breakthrough therapeutic varieties, with no similar products approved globally [8] - Huakang Clean signed a pre-bid for a 157 million yuan procurement project for special hospital departments [9] - Xingyuan Zhuomei received a supplier designation notification from a domestic new energy vehicle manufacturer, with expected sales of approximately 575 million yuan over four years from 2027 to 2030 [9] - Samsung Medical's subsidiary signed a contract for the Brazil CPFL smart meter project, totaling 106 million reais, approximately 135 million yuan [9] - Enhua Pharmaceutical's subsidiary signed an exclusive commercial cooperation agreement with Green Leaf Pharmaceutical and its subsidiary Green Leaf Jiaao [10]

Group 1 - Jizhi Co., Ltd. plans to acquire at least 51% equity in Pumai Technology through cash payment, aiming to gain control over the company, which is a leading enterprise in the field of robot performance testing and calibration in China [1] - Yaxing Chemical's subsidiary intends to transfer 7.14% equity for 60 million yuan to another fund under the same control, indicating strategic investment movements within the same management group [2] - Weigao Bio's application for clinical trials of subcutaneous human immunoglobulin has been accepted by the National Medical Products Administration, targeting primary immunodeficiency diseases [3] Group 2 - Sentai Co., Ltd.'s controlling shareholder plans to increase shareholding by at least 100 million yuan within 12 months, aiming to enhance confidence in the company's future [4] - Health元's subsidiary has received acceptance for the marketing authorization application of Lecanemab injection, which is intended for moderate to severe plaque psoriasis patients [5][11] - Sunshine Nuohuo has signed a technical development contract for the STC008 injection project, with a total payment of 500 million yuan, indicating significant investment in cancer treatment [6] Group 3 - Hunan YN has been designated as a delivery warehouse for lithium carbonate by the Guangzhou Futures Exchange, enhancing its position in the lithium market [7] - Tianji Co., Ltd. is pushing for the industrialization of lithium sulfide material preparation, although it faces risks in commercialization [8] - Yuandong Bio has received FDA approval for Methylene Blue injection, expanding its product portfolio in the U.S. market [10] Group 4 - Nanshan Aluminum has established a wholly-owned subsidiary in Hainan with an investment of 5 million yuan, focusing on high-end aluminum products [13] - ST Xifa plans to acquire 50% equity in Lhasa Beer, aiming for full ownership, with the transaction currently in the planning stage [14] - Hengrui Medicine's SHR-A1904 injection has been included in the list of breakthrough therapy products, indicating its potential in treating advanced gastric cancer [12] Group 5 - Chengdu Gas is planning to merge three subsidiaries, streamlining operations and enhancing efficiency [26] - Baoli Electric intends to invest 50 million yuan to establish a wholly-owned subsidiary focused on key equipment and solutions in energy storage [27] - Huadian International has successfully put the second unit of its Longkou Phase IV project into commercial operation, marking a significant milestone in its energy production capacity [34]

（原标题：春光科技(603657.SH)：签订产品采购合同并获得客户订单） 格隆汇12月24日丨春光科技(603657.SH)公布，公司与苏州乐享智能科技有限公司签署了《战略合作协议》，并于近期签订了《OEM/ODM 产品采 购合同》。 公司本次获得客户的机器人产品采购订单，标志着公司的制造工艺与技术获得了客户的认可，为公司后续拓展机器人产品业务奠定了基础。公司 业务主要为机器人产品 OEM/ODM 代工，预计本次客户订单的履行对2026年净利润影响金额约600万元，对公司营业收入、净利润的影响最终以 审计结果为准。 | 食品饮料ETF | | | --- | --- | | (产品代码: 515170) | | | ★ 跟踪：中证细分食品饮料产业主题指数 | | | 近五日涨跌:0.54% | 1 | | 市盈率: 20.18倍 | F | | 资金流向: 最新份额为108.9亿份, 减 | B | | 少了8550.0万份，净申 | | | 赎-4803.1万元。 | | | 估值分位：18.48% | f | ...

证券代码：603657 证券简称:春光科技 公告编号：2025-084 金华春光橡塑科技股份有限公司 关于签订产品采购合同并获得 客户订单的自愿披露公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 5、交货要求：按订单交货 一、采购合同概况 金华春光橡塑科技股份有限公司（以下简称"公司"）与苏州乐享智能科技 有限公司（以下简称"乐享科技"）签署了《战略合作协议》，并于近期签订了 《OEM/ODM 产品采购合同》。 （一）采购合同主要条款 甲方：苏州乐享智能科技有限公司 乙方：金华春光橡塑科技股份有限公司 经甲乙双方友好共同协商，就甲方向乙方 OEM/ODM"W1"和"M1"机器 人产品价格的有关事宜，以产品累计订单量为依据，执行阶梯式订单价格。 1、付款条件：月结 60 天，现汇 2、税率/币种：增值税 13%/RMB 3、合同周期：2025 年 12 月 1 日至 2026 年 12 月 31 日 4、品质要求：符合乐享科技品质要求 6、甲方向乙方提供真实可行的装配工艺文件，并协助乙方建设前述专用产 线，必要时向专用产线 ...

Core Viewpoint - The company has signed a strategic cooperation agreement and an OEM/ODM product procurement contract with Suzhou Lexiang Intelligent Technology Co., Ltd, securing a procurement order for robot products worth 43.2628 million yuan [1] Group 1: Strategic Developments - The company has entered into a strategic cooperation agreement with Lexiang Technology, indicating a commitment to collaboration in the robotics sector [1] - The procurement order includes the company's OEM/ODM "W1" and "M1" robot products, showcasing the company's capabilities in manufacturing and technology [1] Group 2: Financial Impact - The fulfillment of the current customer order is expected to contribute approximately 6 million yuan to the company's net profit by 2026 [1]